Heart Failure - NYHA II - IV
13
4
6
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (13)
Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
Ted Rogers Understanding of Exacerbations in Heart Failure 2: Monitor
An Optimization Pilot to Optimize An Early Palliative Care Intervention for Advanced Heart Failure
Remote Monitoring of Cardiac Mechanics in Heart Failure Patients
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Cardiovascular Performance and Exercise Response in Patients With Persistent or Permanent Atrial Fibrillation and Heart Failure Pre and Post Cardioversion or Pace and Ablate
Effects of a 20-Minute Mindfulness-Based Breathing Exercise on Dyspnea, Fatigue, and Sleep Quality in Patients With Heart Failure
Low Dose Radiotherapy for Heart Failure
Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure Patients
Calibration of AlgoRithm for Detection of Cardiac Decompensation Via Parametric Objects (CARDCOP)
Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Resynchronization Therapy